Developments in oral immunization delivery viewed as potential weapon to combat global health threats such as tuberculosis, AIDS and diarrheas
Scientists at The Forsyth Institute and Tufts University have succeeded in describing and validating a unique system of oral vaccine delivery using a common bacteria found in the mouth. Findings published today by Elsevier in Microbes and Infection identify Streptococcus mitis as a successful vector for oral mucosal immunization, and further research will determine its potential clinical use in tuberculosis vaccine development.
“Although injected vaccines are traditionally viewed as effective means of immunization to protect internal organs, these vaccines rarely induce strong mucosal protection in the gastrointestinal tract, respiratory tract and genitalia. In contrast, oral vaccinations have the potential to affordably, safely and effectively protect these areas, thus assisting in the fight against global health threats including diarrheas and diseases such as tuberculosis and AIDS,” said lead research Dr. Antonio Campos-Neto, a senior member of the Department of Immunology and Infectious Diseases at The Forsyth Institute. Dr. Campos-Neto is also the director for the Center for Global Infectious Disease Research, and lecturer at the Harvard School of Dental Medicine.
According to the World Health Organization, nine million people were diagnosed with tuberculosis in 2013, the latest year in which data is available, and 1.5 million people died from the disease. It is second only to HIV/AIDS in prevalence.
Read more: Scientists’ unique system of oral vaccine delivery to address global health threats
The Latest on: Oral vaccine
[google_news title=”” keyword=”oral vaccine” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Oral vaccine
- Lower Dose MPox Vaccine: Safe With Equal Six-Week Antibody Responseon April 27, 2024 at 8:07 am
Lower dose of monkeypox vaccine is found to be safe with equal six-week antibody response, promising for vaccination strategies.
- Cholera Oral Vaccine: WHO Prequalifies a New Simplified Vaccineon April 26, 2024 at 3:54 am
The World Health Organization (WHO) has prequalified a new oral cholera vaccine, a simplified formulation that will help increase its production capacity.
- Demand for the cholera vaccine is soaring – this company might have a solutionon April 25, 2024 at 9:02 am
In the global race to provide enough vaccines to tackle the ever-growing threat posed by cholera, one company is leading the field.
- India eyes to increase oral polio vaccine supplyon April 25, 2024 at 5:10 am
New Delhi: The Centre is looking to increase the manufacturing capacity of oral polio vaccine (OPV), said Union Health and Family Welfare Secretary Apurva Chander. Chander is currently touring ...
- Netherlands: Health Secy visits Bilthoven Biologicals, discusses collaboration on production of oral polio vaccineon April 24, 2024 at 6:18 pm
The Union Health Secretary met with CEO Juergen Kwik and CEO of Poonawalla Science Park (PSP) at Bilthoven Jef De Clercq on EU pandemic preparedness partnership and collaboration on production of ...
- WHO prequalifies new oral simplified vaccine for choleraon April 23, 2024 at 1:55 am
A new oral vaccine for cholera has received prequalification by the World Health Organization (WHO). The inactivated oral vaccine Euvichol-S has a similar efficacy to existing vaccines but a ...
- World Health Organization prequalifies simplified oral cholera vaccine Euvichol-Son April 22, 2024 at 4:29 am
The World Health Organization (WHO) has prequalified a new inactivated and simplified oral vaccine for cholera, Euvichol-S, to “rapidly increase” production capacity to overcome global shortages. The ...
- WHO prequalifies new simplified oral vaccine for choleraon April 22, 2024 at 12:00 am
While similar in efficacy to existing vaccines, the inactivated oral vaccine has a simplified formulation, allowing opportunities to rapidly increase production capacity ...
- WHO prequalifies new oral vaccine for cholera; Here’s what you need to knowon April 19, 2024 at 4:48 am
Euvichol-S is a simplified formulation of the oral cholera vaccine (OCV) Euvichol-Plus. The vaccine is manufactured by South Korea-based EuBiologics Co., Ltd.
- Easier-to-Make Cholera Vaccine Approved by WHO Amid Shortageon April 19, 2024 at 2:06 am
An oral vaccine for cholera that is more simple to make than existing versions has been approved by the World Health Organization in a move that is expected to rapidly increase production capacity ...
via Bing News